Nalaganje...
Development of TRPM8 Antagonists to Treat Chronic Pain and Migraine
A review. Development of pharmaceutical antagonists of transient receptor potential melastatin 8 (TRPM8) have been pursued for the treatment of chronic pain and migraine. This review focuses on the current state of this progress.
Shranjeno v:
| izdano v: | Pharmaceuticals (Basel) |
|---|---|
| Main Authors: | , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
MDPI
2017
|
| Teme: | |
| Online dostop: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5490394/ https://ncbi.nlm.nih.gov/pubmed/28358322 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ph10020037 |
| Oznake: |
Označite
Brez oznak, prvi označite!
|